Drug-induced orthostatic hypotension. A five-year experience in a regional pharmacovigilance centre in France

Clinical Drug Investigation

Volumn 14, Issue 1, 1997, Pages 61-65

  Montastruc, J L ^a   Laborie, I ^a   Bagheri, H ^a   Senard, J M ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANGINA PECTORIS AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CARPIPRAMINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOT DERIVATIVE; FLUPENTIXOL; GLYCERYL TRINITRATE; IFENPRODIL; IMIPRAMINE; LABETALOL; LEVODOPA; LOOP DIURETIC AGENT; MOLSIDOMINE; MONOAMINE OXIDASE B INHIBITOR; NEUROLEPTIC AGENT; PROPRANOLOL; TRIMETAZIDINE; UNINDEXED DRUG; URAPIDIL; VASODILATOR AGENT; VERAPAMIL; VIDARABINE;

ADULT; AGED; ARTICLE; DRUG MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL;

EID: 0030854661     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199714010-00008     Document Type: Article

References (19)

1. Senard JM, Montastruc JL. Which drug for which orthostatic hypotension? Fundam Clin Pharmacol 1996; 10: 225-33
2. Mathias CJ. Orthostatic hypotension: causes, mechanisms and influencing factors. Neurology 1995; 5 Suppl. 5: 6-11
3. Ensrud KE, Nevitt MC, Yunis C, et al. Postural hypotension and postural dizziness in elderly women. The study of osteoporotic fractures. Arch Intern Med 1992; 152: 1058-64
4. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in the older adults. The cardiovascular health study. Hypertension 1992; 19: 508-19
5. Räihä I, Luutonen S, Piha J, et al. Prevalence predisposing factors and prognosis importance of postural hypotension. Arch Intern Med 1995; 155: 930-5
6. Bannister R, Mathias CJ. Introduction and classification of autonomic disorders. In: Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. Vol. 1. Bannister R, Mathias CJ, editors. Oxford: Oxford University Press, 1992; 1-12
7. Mets TF. Drug-induced orthostatic hypotension in older patients. Drugs Aging 1995; 6: 219-28
8. Hugues FC, Munera Y, Le Jeunne C. Drug-induced orthostatic hypotension. Rev Med Interne 1992; 13: 465-70
9. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996; 46: 1470
10. World Health Organization Collaborating Centre for International Drug Monitoring. Definitions - serious, severe reactions [letter]. OMS Report 1993 23: 18-93
11. Begaud B, Jouglard J, Evreux JC, et al. Unexpected or toxic drug reaction assessment (imputation). Actualisation of the method used in France. Therapie 1985; 40: 111-8
12. Rawlins MD. Spontaneous reporting of adverse drug reactions. I. The Data. Br J Clin Pharmacol 1988; 26: 1-5
13. Rawlins MD. Spontaneous reporting of adverse drug reactions. II. Uses. Br J Clin Pharmacol 1988; 26: 7-11
14. Montastruc JL, Rascol O, Senard JM. Current status of dopamine agonists in Parkinson's disease management. Drugs 1993; 46: 384-93
15. Durrieu G, Senard JM, Tran MA, et al. Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians. Clin Neuropharmacol 1991; 14: 84-90
16. Möller HJ, Volz HP. Drug treatment of depression in the 1990s: an overview of achievements and future possibilities. Drugs 1996; 52: 625-38
17. Rostin M, Montastruc JL, Senard JM, et al. Pharmacologie clinique et bases du traitement de l'hypotension orthostalique. Thérapie 1987; 42: 41-4
18. Schatz IJ. Orthostatic hypotension. Vol. 1. F.A. Davis Company, Philadelphia 1986
19. Senard JM, Chamontin B, Rascol A, et al. Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension. Clin Auton Res 1992; 2: 99-104